157 related articles for article (PubMed ID: 35219846)
1. Sodium molybdate inhibits the growth of ovarian cancer cells via inducing both ferroptosis and apoptosis.
Mao G; Xin D; Wang Q; Lai D
Free Radic Biol Med; 2022 Mar; 182():79-92. PubMed ID: 35219846
[TBL] [Abstract][Full Text] [Related]
2. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Li D; Zhang M; Chao H
Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
[TBL] [Abstract][Full Text] [Related]
3. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
[TBL] [Abstract][Full Text] [Related]
4. Linoleic Acid-Glucosamine Hybrid for Endogenous Iron-Activated Ferroptosis Therapy in High-Grade Serous Ovarian Cancer.
Chen Y; Liao X; Jing P; Hu L; Yang Z; Yao Y; Liao C; Zhang S
Mol Pharm; 2022 Sep; 19(9):3187-3198. PubMed ID: 35939328
[TBL] [Abstract][Full Text] [Related]
5. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
[TBL] [Abstract][Full Text] [Related]
6. Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.
Battaglia AM; Sacco A; Perrotta ID; Faniello MC; Scalise M; Torella D; Levi S; Costanzo F; Biamonte F
Front Oncol; 2022; 12():868351. PubMed ID: 35433479
[TBL] [Abstract][Full Text] [Related]
7. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer.
Lou JS; Zhao LP; Huang ZH; Chen XY; Xu JT; Tai WC; Tsim KWK; Chen YT; Xie T
Phytomedicine; 2021 Jan; 80():153370. PubMed ID: 33113504
[TBL] [Abstract][Full Text] [Related]
8.
Xia L; Yang M; Liu Y
Aging (Albany NY); 2024 Mar; 16(6):5108-5122. PubMed ID: 38503553
[TBL] [Abstract][Full Text] [Related]
9. Agrimonolide inhibits cancer progression and induces ferroptosis and apoptosis by targeting SCD1 in ovarian cancer cells.
Liu Y; Liu X; Wang H; Ding P; Wang C
Phytomedicine; 2022 Jul; 101():154102. PubMed ID: 35526323
[TBL] [Abstract][Full Text] [Related]
10. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
11. Verticillin A Causes Apoptosis and Reduces Tumor Burden in High-Grade Serous Ovarian Cancer by Inducing DNA Damage.
Salvi A; Amrine CSM; Austin JR; Kilpatrick K; Russo A; Lantvit D; Calderon-Gierszal E; Mattes Z; Pearce CJ; Grinstaff MW; Colby AH; Oberlies NH; Burdette JE
Mol Cancer Ther; 2020 Jan; 19(1):89-100. PubMed ID: 31909733
[TBL] [Abstract][Full Text] [Related]
12. Activatable nanomedicine for overcoming hypoxia-induced resistance to chemotherapy and inhibiting tumor growth by inducing collaborative apoptosis and ferroptosis in solid tumors.
Fu J; Li T; Yang Y; Jiang L; Wang W; Fu L; Zhu Y; Hao Y
Biomaterials; 2021 Jan; 268():120537. PubMed ID: 33260096
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis: A New Promising Target for Ovarian Cancer Therapy.
Zhao H; Xu Y; Shang H
Int J Med Sci; 2022; 19(13):1847-1855. PubMed ID: 36438923
[TBL] [Abstract][Full Text] [Related]
14. Superparamagnetic Iron Oxide Nanoparticles Induce Ferroptosis of Human Ovarian Cancer Stem Cells by Weakening Cellular Autophagy.
Huang Y; Lin J; Xiong Y; Chen J; Du X; Liu Q; Liu T
J Biomed Nanotechnol; 2020 Nov; 16(11):1612-1622. PubMed ID: 33461653
[TBL] [Abstract][Full Text] [Related]
15. Curcumin derivative NL01 induces ferroptosis in ovarian cancer cells via HCAR1/MCT1 signaling.
Shi M; Zhang MJ; Yu Y; Ou R; Wang Y; Li H; Ge RS
Cell Signal; 2023 Sep; 109():110791. PubMed ID: 37406786
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase UCHL1 Maintains Protein Homeostasis through the PSMA7-APEH-Proteasome Axis in High-grade Serous Ovarian Carcinoma.
Tangri A; Lighty K; Loganathan J; Mesmar F; Podicheti R; Zhang C; Iwanicki M; Drapkin R; Nakshatri H; Mitra S
Mol Cancer Res; 2021 Jul; 19(7):1168-1181. PubMed ID: 33753553
[TBL] [Abstract][Full Text] [Related]
17. A self-amplified ferroptosis nanoagent that inhibits the tumor upstream glutathione synthesis to reverse cancer chemoresistance.
Yang C; Chen Z; Wei M; Hu S; Cai M; Wang N; Guan Y; Li F; Ding Q; Ling D
J Control Release; 2023 May; 357():20-30. PubMed ID: 36940774
[TBL] [Abstract][Full Text] [Related]
18. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis.
Chen P; Wu Q; Feng J; Yan L; Sun Y; Liu S; Xiang Y; Zhang M; Pan T; Chen X; Duan T; Zhai L; Zhai B; Wang W; Zhang R; Chen B; Han X; Li Y; Chen L; Liu Y; Huang X; Jin T; Zhang W; Luo H; Chen X; Li Y; Li Q; Li G; Zhang Q; Zhuo L; Yang Z; Tang H; Xie T; Ouyang X; Sui X
Signal Transduct Target Ther; 2020 May; 5(1):51. PubMed ID: 32382060
[TBL] [Abstract][Full Text] [Related]
19. JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancer.
Liu B; Huang X; Li Y; Liao W; Li M; Liu Y; He R; Feng D; Zhu R; Kurihara H
BMC Cancer; 2019 Jul; 19(1):645. PubMed ID: 31262254
[TBL] [Abstract][Full Text] [Related]
20. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
